We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

229 hedge funds and large institutions have $188M invested in Editas Medicine in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $1.14M

6% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 64

1.71% less ownership

Funds ownership: 68.57% → 66.86% (-1.7%)

3% less funds holding

Funds holding: 235 → 229 (-6)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $263M → $188M (-$75.6M)

Holders
229
Holders Change
-6
Holders Change %
-2.55%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
68
Reduced
64
Closed
41
Calls
$1.5M
Puts
$1.14M
Net Calls
+$362K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.88M
2
Two Sigma Investments
Two Sigma Investments
New York
+$3.56M
3
APM
Avidity Partners Management
Texas
+$2.83M
4
Jane Street
Jane Street
New York
+$2.5M
5
CSS
Cubist Systematic Strategies
Connecticut
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$9.27M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$5.89M
3
DTC
Deep Track Capital
Connecticut
-$4.79M
4
IHAM
Integral Health Asset Management
New York
-$3.15M
5
Squarepoint
Squarepoint
New York
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$1.61M +$2.05M +471,208 New
HF
27
HRT Financial
New York
$1.53M +$654K +150,267 +50%
UBS Group
28
UBS Group
Switzerland
$1.4M +$298K +68,488 +20%
AQR Capital Management
29
AQR Capital Management
Connecticut
$1.28M +$1.44M +330,307 +720%
Citadel Advisors
30
Citadel Advisors
Florida
$1.19M +$557K +127,916 +58%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$1.14M +$91.5K +21,026 +7%
SOMRS
32
State of Michigan Retirement System
Michigan
$933K – – –
N
33
Nuveen
North Carolina
$873K – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$828K -$232K -53,241 -18%
Jennison Associates
35
Jennison Associates
New York
$811K +$491K +112,857 +90%
HWAM
36
Hennion & Walsh Asset Management
New Jersey
$773K +$254K +58,385 +35%
Fidelity Investments
37
Fidelity Investments
Massachusetts
$693K +$464K +106,684 +111%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$630K -$1.59M -366,138 -66%
GCP
39
GSA Capital Partners
United Kingdom
$623K +$374K +86,020 +89%
Barclays
40
Barclays
United Kingdom
$609K +$248K +56,986 +47%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$593K +$592K +136,068 +358%
Mirae Asset Global ETFs Holdings
42
Mirae Asset Global ETFs Holdings
Hong Kong
$586K -$144K -33,171 -16%
Swiss National Bank
43
Swiss National Bank
Switzerland
$524K – – –
American Century Companies
44
American Century Companies
Missouri
$505K +$94.6K +21,731 +17%
Prudential Financial
45
Prudential Financial
New Jersey
$496K +$184K +42,369 +41%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$484K +$16.9K +3,889 +3%
DMKJ
47
David M. Knott Jr
$463K -$179K -41,147 -23%
AllianceBernstein
48
AllianceBernstein
Tennessee
$460K – – –
Los Angeles Capital Management
49
Los Angeles Capital Management
California
$401K -$57.9K -13,310 -10%
CANY
50
Caxton Associates (New York)
New York
$390K -$61.6K -14,147 -11%
1
2
3 4 5

EDIT Hedge Fund Activity: Q3 2024 in Review

229 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2024, worth a combined $188M — down 29% from $263M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of EDIT and 36 opened new positions — a net loss of 5 holders — while 64 trimmed existing stakes and 68 added.

The largest buyer was Millennium Management, adding an estimated $3.88M. The largest seller was State Street, cutting an estimated $9.27M.

  • 229 institutional investors held Editas Medicine (EDIT) as of Q3 2024, down from 235 in Q2 2024.
  • Funds reported $188M of Editas Medicine stock for Q3 2024, down 29% quarter-over-quarter.
  • 36 funds opened new Editas Medicine positions in Q3 2024 and 41 closed out, a net change of -5 holders.
  • The largest Editas Medicine buyer in Q3 2024 was Millennium Management, an estimated $3.88M added.
  • The largest Editas Medicine seller in Q3 2024 was State Street, an estimated $9.27M sold.

Based on aggregated 13F filings for Q3 2024.